AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 171 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,442,000 | +44.8% | 41,200 | +179.0% | 0.04% | +54.2% |
| Q1 2019 | $996,000 | +60.4% | 14,765 | +100.2% | 0.02% | +118.2% |
| Q2 2018 | $621,000 | -32.2% | 7,375 | -34.2% | 0.01% | -21.4% |
| Q1 2018 | $916,000 | -33.3% | 11,200 | -45.6% | 0.01% | -26.3% |
| Q3 2017 | $1,374,000 | +12.2% | 20,574 | -1.9% | 0.02% | +26.7% |
| Q1 2017 | $1,225,000 | -61.7% | 20,977 | -27.0% | 0.02% | -75.8% |
| Q2 2015 | $3,195,000 | – | 28,750 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |